Technology Center Malta: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Center Malta.

Press releases published on October 5, 2026

5 hours ago

Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and United Kingdom

Indeterminate GlobeNewswire

5 hours ago

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly

Indeterminate GlobeNewswire

5 hours ago

Benitec Biopharma Announces Regulatory Update Following Type C Meeting with FDA for BB-301 Pivotal Study

Indeterminate GlobeNewswire

5 hours ago

Zscaler Collaborates with IBM and Red Hat to Protect Private Applications from Frontier AI-Powered Threats

Indeterminate GlobeNewswire

5 hours ago

Coveron completes SOC 2 Type II certification with zero exceptions

Indeterminate GlobeNewswire

5 hours ago

Mastercard Selects Rezolve Ai in Worldwide Reseller Agreement to Advance AI-Powered Commerce

Indeterminate GlobeNewswire

5 hours ago

Synoptic Data Secures Lead Subcontractor Role on NOAA’s Five-Year, $1.1B Ceiling National Mesonet Program Contract

Indeterminate GlobeNewswire

5 hours ago

AGM Group Holdings Inc. Announces Closing of US$11.0 million Private Placement

Indeterminate GlobeNewswire

5 hours ago

Polyrizon Files for U.S. Patent Application to Expand IP Moat Around Intranasal Drug-Delivery Platform

Indeterminate GlobeNewswire

5 hours ago

Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors

Indeterminate GlobeNewswire

5 hours ago

BBP-418 Demonstrates Potential to Be Disease Modifying Therapy, Restoring Cardiac and Disease Markers to Unaffected Levels

Indeterminate GlobeNewswire

5 hours ago

FIERCE BIOTECH NAMES REPRONOVO A “FIERCE 15” BIOTECH COMPANY OF 2026

Indeterminate GlobeNewswire

5 hours ago

Kraig Biocraft Laboratories Ramps Full Production Across All Three Production Centers as Commercial Deliveries Begin to Take Hold

Indeterminate GlobeNewswire

5 hours ago

Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data in Multiple System Atrophy at the 2026 International Congress of Parkinson’s Disease and Movement Disorders

Indeterminate GlobeNewswire

6 hours ago

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 

Indeterminate GlobeNewswire

6 hours ago

Coave Therapeutics Presents Non-Human Primate Data Supporting Lead Wet AMD Gene Therapy Program at Euretina 2026

Indeterminate GlobeNewswire

6 hours ago

Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences

Indeterminate GlobeNewswire

6 hours ago

Satellos Granted Composition of Matter Patent for Forazapadin

Indeterminate GlobeNewswire

6 hours ago

Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial

Indeterminate GlobeNewswire

6 hours ago

Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine

Indeterminate GlobeNewswire